Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial-Reference-Cited by-同舟云学术

Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial

Published:2023-08 Issue:8 Volume:22 Page:672-684
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Maynard George,Kannan Ramakrishnan,Liu Jian,Wang Weiwei,Lam Tu Kiet T,Wang Xingxing,Adamson Crista,Hackett Craig,Schwab Jan M,Liu Charles,Leslie Donald P,Chen David,Marino Ralph,Zafonte Ross,Flanders Adam,Block Gilbert,Smith Erika,Strittmatter Stephen M

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference46 articles.

1. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Lancet Neurol,2019

2. Regulation of axonal regeneration after mammalian spinal cord injury;Zheng;Nature,2023

3. Axon regeneration in the peripheral and central nervous systems;Huebner;Results Probl Cell Differ,2009

4. Intrinsic Control of Axon Regeneration;He;Neuron,2016

5. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein;GrandPré;Nature,2000

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacologic Therapy for Spinal Cord Injury;Clinical Spine Surgery;2024-09-12

2. How does Nogo-A signalling influence mitochondrial function during multiple sclerosis pathogenesis?;Neuroscience & Biobehavioral Reviews;2024-08

3. Advances and Challenges in Spinal Cord Injury Treatments;Journal of Clinical Medicine;2024-07-13

4. Pharmacological intervention for chronic phase of spinal cord injury;Neural Regeneration Research;2024-06-26

5. Proteomics in orthopedic research: Recent studies and their translational implications;Journal of Orthopaedic Research;2024-06-19